Federal Register / Vol. 72, No. 96 / Friday, May 18, 2007 / Notices 28077 

class of controlled substance listed in 

schedule I. 

The company plans on manufacturing 

this controlled substance for sale to its 

customers. These customers will sell the 

drug in small quantities for research 

purposes or as drug standards for 

forensic laboratories. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Organix Inc. to manufacture the listed 

basic class of controlled substance is 

consistent with the public interest at 

this time. DEA has investigated Organix 

Inc. to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with State 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic class of controlled substance 

listed. 

Dated: May 14, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–9630 Filed 5–17–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

This is notice that on March 7, 2007, 

Penick Corporation, 33 Industrial Park 

Road, Pennsville, New Jersey 08070, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) for registration as an importer of 

the basic classes of controlled 

substances listed in schedule II: 

Drug Schedule 

Coca Leaves (9040) ..................... II 

Raw Opium (9600) ....................... II 

Poppy Straw (9650) ..................... II 

Concentrate of Poppy Straw 

(9670).

II 

The company plans to import the 

listed controlled substances to 

manufacture bulk controlled substance 

intermediates for sale to its customers. 

As noted in a previous notice 

published in the Federal Register on 

September 23, 1975, (40 FR 43745), all 

applicants for registration to import a 

basic class of any controlled substances 

in schedule I or II are, and will continue 

to be required to demonstrate to the 

Deputy Assistant Administrator, Office 

of Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a), 21 U.S.C. 823(a), and 21 

CFR 1301.34(b), (c), (d), (e) and (f) are 

satisfied. 

Dated: May 10, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–9645 Filed 5–17–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated November 28, 2006, 

and published in the Federal Register 

on December 7, 2006, (71 FR 70988), 

Rhodes Technologies, 498 Washington 

Street, Coventry, Rhode Island 02816, 

made application by letter to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

Oxymorphone (9652), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to manufacture 

the listed controlled substance in bulk 

for conversion and sale to dosage form 

manufacturers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Rhodes Technologies to manufacture 

the listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Rhodes Technologies to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with State and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: May 14, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–9614 Filed 5–17–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated October 31, 2006, and 

published in the Federal Register on 

November 7, 2006, (71 FR 65135), 

Siegfried (USA), Inc., Industrial Park 

Road, Pennsville, New Jersey 08070, 

made application by letter to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the basic classes of controlled 

substances listed in schedule I and II: 

Drug Schedule 

Dihydromorphine (9145) ............... I 

Oxymorphone (9652) ................... II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution to its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Siegfried (USA), Inc. to manufacture the 

listed basic class of controlled substance 

is consistent with the public interest at 

this time. DEA has investigated 

Siegfried (USA), Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with State and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: May 14, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–9615 Filed 5–17–07; 8:45 am] 

BILLING CODE 4410–09–P 


pwalker on PROD1PC71 with NOTICES